Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

Cheung A., Gong M., Bellanti R., Ali-Hasan-Al-Saegh S., Li G., Roig E., ...Daha Fazla

HEART ASIA, cilt.10, sa.1, 2018 (ESCI İndekslerine Giren Dergi) identifier identifier identifier


Background Cancer antigen-125 (Ca-125) is traditionally recognised as a tumour marker and its role in cardiovascular diseases has been studied only in recent years. Whether Ca-125 is elevated in patients with atrial fibrillation (AF) and its levels predict the risk of AF remains controversial. Therefore, we conducted a systematic review and meta-analysis of the association between Ca-125 levels and AF.